Endorsed by the World Health Assembly in 2012, the Global Vaccine Action Plan 2011-2020 (6) calls on all countries to reach ≥90% national coverage and ≥80% coverage in every district or equivalent administrative unit for all vaccines in the country's national immunization schedule by 2020. DTP3 coverage by age 12 months is an indicator of immunization program performance (2) . During 2015, a total of 116 million children received DTP3; DTP3 coverage ranged from 76% in the WHO African Region to 94% in the Western Pacific Region (Table 1) . National DTP3 coverage estimates ranged from 16% to 99% and the national DTP1 (first dose of DTP) to DTP3 dropout rates (the proportion of children who received DTP1 but did not receive DTP3) ranged from 0% to 61%. Overall, 124 (65%) countries achieved ≥90% national DTP3 coverage (Table 2 ). National DTP3 coverage was 80%-89% in 34 countries, 70%-79% in 12 countries, and <70% in 22 countries. Among the 19.4 million children worldwide who did not receive 3 DTP doses during the first year of life, 11.7 million (60%) lived in 10 countries (Figure) . Among all children who did not complete the 3-dose DTP series, 12.8 million (66%) never received the first DTP dose, and 6.6 million (34%) started, but did not complete the series.
DTP3 coverage estimates in low-income countries were lower than in higher-income countries (Table 2) (7) . Complete subnational coverage data, based on country-reported administrative sources, were available for 158 countries in 2015; among these, 54 (34%) reported achieving ≥80% DTP3 coverage in every district, and 21 (13%) reported that ≥10% of districts had DTP3 coverage <50%.
MCV1 coverage in 2015 ranged from 74% in the African Region to 96% in the Western Pacific Region (Table 1) and from 20% to 99% by country; MCV2 coverage varied from 18% to 93% by region and from 8% to 99% by country. Globally, 119 (61%) countries achieved the ≥90% * The original EPI vaccines were Bacille Calmette-Guérin vaccine (BCG) (to protect against tuberculosis), polio vaccine (Pol), measles-containing vaccine (MCV), and diphtheria-tetanus-pertussis vaccine (DTP). † Administrative coverage is calculated as the number of vaccine doses administered to persons in a specified target group divided by the estimated target population. § During vaccination coverage surveys, a representative sample of households are visited and caregivers of children in a specified target group (aged 12-23 months) are interviewed. Dates of vaccination are transcribed from the child's homebased record or are recorded based on caregiver recall or from health facility records. Coverage is calculated as the proportion of persons in a target age group who received a vaccine dose. ¶ Gavi Phase 2 classification (73 eligible countries).
national MCV1 coverage target,** including 51 (91%) of 56 high-income countries and five (16%) of 31 low-income countries ( Table 2) .
During 2010-2015, global coverage increased for completed series of rotavirus (from 8% to 23%), PCV (11% to 37%), rubella (35% to 46%), Hib (42% to 64%) and HepB (74% to 84%) vaccines (Table 1) ]. For the universally recommended vaccines that have been introduced globally into national schedules of most (>80%) countries, coverage estimates in low-income countries were lower than those in higher-income countries (Table 2) . Among the 50 lower middle-income countries, a higher percentage of the 13 non-Gavi-eligible lower middle-income countries had achieved ≥90% national vaccination coverage than had the 37 Gavi-eligible lower middle-income countries for MCV1 (54% in non-Gavi eligible versus 38% in Gavi-eligible lower middle-income countries), MCV2 (31% versus 24%), DTP3 (46% versus 43%), Pol3 (54% versus 43%), HepB3 (46% versus 43%), and Hib3 (46% versus 43%).
Discussion
Commitment by country governments and the collaboration of multiple global immunization partners has led to a reduction in the number of incompletely vaccinated children to an all-time low of 19.4 million in 2015. Since 2000, approximately 70 low-and middle-income countries have benefitted from Gavi support to increase equitable use of vaccines by strengthening health systems and accelerating the introduction and use of newer and underused vaccines such as PCV and rotavirus and rubella vaccines. However, despite substantial progress in increasing the number of children vaccinated worldwide, global DTP3, MCV1 and Pol3 coverage has remained at 84%-86% since 2010, with coverage improving in some countries and deteriorating in others; 68 (35%) countries have not yet met the Global Vaccine Action Plan 2011-2020 target of 90% national DTP3 coverage. Coverage varies widely among and within WHO Regions, countries, and communities. Even though vaccines are being introduced into low-income countries more rapidly than ever before (8) , equity in coverage has not yet been achieved, and disparities exist, even for vaccines with long-standing recommendations, such as DTP and MCV, with higher coverage in higher-income countries. Furthermore, in lower middle-income countries, vaccination coverage in Gavi-eligible countries still lags behind coverage in non-Gavi-eligible countries despite Gavi support, and nine of the 10 countries with the largest number of incompletely vaccinated children are current or former Gavi-eligible countries, indicating that continued Gavi support for immunization system strengthening is necessary. Ensuring that eligible persons within each district are fully vaccinated according to the national schedule regardless of location, age, sex, ethnicity, educational level, and socioeconomic level is a considerable challenge to the successful delivery of equitable immunization services.
WHO/UNICEF vaccination coverage estimates are supported by or based on vaccination coverage surveys that disaggregate coverage data by demographic and other factors. BCG  158  88  80  95  87  89  87  96  HepB BD  97  39  10  72  23  39  34  83  HepB3  185  84  76  89  80  81  87  90  DTP3  194  86  76  91  80  93  87  94  Hib3  191  64  76  90  80  77  56  25  Pol3  194  86  76  91  80  94  86  96  Rota  84  23  41  76  21  18  0  1  PCV3  129  37  59  85  48  48  5  11  MCV1  194  85  74  94  76  94  85  96  RCV1  147  46  12  94  45  94  14  89  MCV2  160  61  18  53  68  89 and increases with higher economic status in most low-and middle-income countries (9) . These surveys also indicate that coverage is generally higher in urban than rural areas and increases with level of mother's education; no significant differences in coverage are observed by sex.
The findings in this report are subject to at least two limitations. First, inaccuracy in estimation of target population figures might result in over-or under-estimation of administrative coverage. Second, parental recall bias could lead to inaccurate estimates of survey-based coverage (2,3). ( Equitable access to immunization is a key goal of the Global Vaccine Action Plan 2011-2020 and is essential to reducing child mortality. Equity-oriented immunization programs that include effective community-centered activities to communicate the value and benefits of vaccination are required to reach marginalized populations and sustain high coverage. Because disease burden is often disproportionately higher in disadvantaged populations, reaching these persons could also have a larger health impact and contribute to economic development (6) . National commitment and ownership of initiatives to introduce new vaccines and achieve high vaccination coverage is essential to the success of such programs.
Although global commitment and Gavi support have improved introduction of new vaccines into low-income countries (8), wide disparities in vaccination coverage by country income group exist, even for vaccines recommended since the inception of the Expanded Program on Immunization. The proportion of lower middle-income countries reaching the Global Vaccine Action Plan 2011-2020 targets of 90% coverage could be improved for both Gavi-eligible and non-Gavi-eligible countries, reflecting that resources are still needed to provide adequate system strengthening even after vaccines have been introduced. Strengthening immunization services, especially in countries with the highest numbers of undervaccinated children, should be a priority to help achieve the United Nation's third Sustainable Development Goal of ending preventable deaths of newborns and children aged <5 years by 2030 (10).
Summary
What is already known about this topic?
In 1974, the World Health Organization (WHO) established the Expanded Program on Immunization to ensure that all children have access to routinely recommended vaccines. Since then, global coverage with vaccines to prevent tuberculosis, diphtheria, tetanus, pertussis, poliomyelitis, and measles has increased from <5% to ≥85%, and additional vaccines have been added to the recommended schedule. Coverage with the third dose of diphtheria-tetanus-pertussis vaccine (DTP3) by age 12 months is an indicator of immunization program performance.
What is added by this report?
Global DTP3 coverage has not increased above 85%-86% since 2010. Vaccination coverage varies widely across WHO Regions, countries, and districts, and between population groups and communities, with lower coverage and higher numbers of under-immunized children in lower-income countries and among children from poorer households.
What are the implications for public health practice?
Equitable access to immunization to achieve and sustain high coverage and reduce child mortality can be enhanced through continued financial and technical support for program strengthening and vaccine introductions in lower-income settings; community engagement to increase vaccination acceptance and demand; the collection and use of high quality vaccination data; and government commitment to initiatives to improve immunization services.
